“…Babaian et al [5] reported that evidence of metastatic disease was found in a postmortem examination in approximately two thirds of patients with bladder cancer. The incidence of clinically detected distant metastases from urothelial carcinoma of the bladder reportedly ranges from 9.5% to 29% [1,6]. Lymph nodes, liver, lung, bone, and peritoneum are the most common metastatic sites of urothelial carcinoma of bladder, whereas skin, brain, heart, and kidney are rarely involved [1-3].…”